期刊文献+

雷公藤内酯醇对阿尔茨海默病模型大鼠海马补体3表达的影响 被引量:2

Effects of triptolide on complement 3 expression of hippocampus in Alzheimer's disease model rats
下载PDF
导出
摘要 目的:观察β-淀粉样蛋白(Aβ)对大鼠海马补体3(C3)表达的变化及雷公藤内酯醇对其的影响.方法:SD雄性大鼠随机等分成对照组、模型组、用药组.在大鼠双侧海马定向注射凝聚态Aβ1-40作为模型组,注射等量生理盐水设为对照组,大鼠在海马注射凝聚态Aβ1-40后腹腔注射雷公藤内酯醇则为用药组.应用免疫组织化学、RT-PCR方法检测各组大鼠海马C3的表达.结果:免疫组织化学显色显示,模型组C3阳性细胞数与对照组比较明显增多、模型组C3阳性细胞平均光密度与对照组比较明显增高.用药组C3阳性细胞平均光密度较模型组明显降低.RT-PCR结果显示,模型组C3 mRNA的表达水平比对照组明显增高;而用药组C3 mRNA的表达水平低于模型组.结论:雷公藤内酯醇对Aβ所致的大鼠海马C3的活化有抑制作用. Objective: To explore the effects of triptolide (TP) and β-amyloid protein (AI3) on complement 3 (123) expression of hippoeampus in model rats with Alzheimer's disease (AD). Methods: Thirty male SD rats were randomly divided into three equal groups: a control group, AD model group and TP-treated group. The AD model group was prepared with bilateral microinjection of aggregated Aβ1-40 into rat hippocampus while the control group was only bilaterally microinjected with normal saline. The TP-treated group was first bilaterally mieroinjeeted with aggregated Aβ1-40 into the hippocampus and then administered intraperitoneally with TP. The variations of C3 expression of hippocampus in these groups were observed by immuno-histoehemical staining and RT-PCR. Results: The cell number of the C3 positive staining in the AD model group (95.42±23. 45) was considerably higher than that in the control group (30. 09±6. 52) and the average optical density of the C3 positive staining in the AD model group (0. 335 1±0. 038 8) was greatly higher than that in the control group (0. 166 4±0. 016 1). It was also found that the average optical density of the C3 positive staining in the TP-treated group (0. 272 1±0. 032 7) was significantly lower than that in the AD model group (0. 335 1±0. 038 8). The RT-PCR gave comparable results that the expression level of C3 mRNA in the AD model group (0. 858±0. 023) was significantly higher than that in the control group (0. 671±0. 034) while the expression level of C3 mRNA in the TP-treated group (0. 772±0. 029) was noticeably lower than that in the model group (0. 858±0. 023). Conclusion: TP can inhibit the activation of hippocampal C3 in the AD model rats.
出处 《解剖学杂志》 CAS CSCD 北大核心 2010年第5期660-663,共4页 Chinese Journal of Anatomy
基金 国家自然科学基金(30660073) 江西省教育厅科技项目计划(赣教技字[2007]87号)
关键词 雷公藤内酯醇 Β-淀粉样蛋白 阿尔茨海默病 补体3 海马 triptolide β-amyloid protein Alzheimer's disease complement 3 hippocampus
  • 相关文献

参考文献10

  • 1Tuppo E E,Arias H R.The role of inflammation in Alzheimer's disease[J].Int J Biochem Cell Biol,2005,37(2):289-305.
  • 2Craft J M,Watterson D M,Van Eldik L J.Human amyloid beta-induced neuroinflammation is an early event in neurodegeneration[J].Glia,2006,53(5):484-490.
  • 3吕诚,胡小令,万斌,杨宝林.雷公藤内酯醇对阿尔茨海默病模型大鼠学习记忆和海马核因子-κB表达的影响[J].中国老年学杂志,2009,29(17):2186-2188. 被引量:14
  • 4Barnum S R.Complement biosynthesis in the central nervous system[J].Crit Rev Oral Biol Med,1995,6(2):132-146.
  • 5Kishore U,Gupta S K,Perdikoulis M V,et al.Modular organization of the carboxyl-terminal,globular head region of humanC1q A,B,and C chains[J].J Immunol,2003,171(2):812-820.
  • 6Mocco J,Mack W J,Ducruet A F,et al.Complement component C3 mediates inflammatory injury following focal cerebral ischemia[J].Circ Res,2006,99(2):209-217.
  • 7Kolev M V,Ruseva M M,Harris C L,et al.Implication of complement system and its regulators in Alzheimer's disease[J].Curr Neuropharmacol,2009,7(1):1-8.
  • 8Mrak R E,Griffin W S.Potential inflammatory biomarkers in Alzheimer's disease[J].J Alzheimers Dis,2005,8(4):369-375.
  • 9Zanjani H,Finch C E,Kemper C,et al.Complement activation in very early Alzheimer disease[J].Alzheimer Dis Assoc Disord,2005,19(2):55-66.
  • 10洪郁芝,陈燕,俞东容,朱斌,朱晓玲,王永钧.雷公藤内酯醇对TNF-α诱导人PTEC补体C_3的影响[J].中国中西医结合肾病杂志,2006,7(8):389-392. 被引量:5

二级参考文献18

共引文献17

同被引文献34

  • 1Markesbery W R.Oxidative stress hypothesis in Alzheimer's disease.Free Rad Biol Med, 1997,23:134-147.
  • 2Huang H C,Jiang Z F.Accumulated amyloid-beta peptide and hyperphosphorylated tau protein:relationship and links in Alzheimer' s disease.J Alzheimers Dis,2009,16( 1 ): 15 -27.
  • 3Calissano P,Matrone C,Amadero G.Apoptosis and in vito Alzheimer disease neuronal models.Commun Integr Biol,2009,2(2): 163-169.
  • 4Xian Y F,Lin Z X,Mao Q Q,et al.Protective effect of isorhynchophylline against beta-amyloid-induced neurotoxicity in PC12cells.Cell Mol Neurobiol,2012,32(3):353-360.
  • 5Qi D,Zhu Y,Wen L,et al.Ginsenoside Rgl restores the imtmirment of learning induced by chronic morphine administration in rats. J Psychopharmacol,2009,23:74-83.
  • 6Mc Geer P L,Rogers J,Mc Geer E G.Neuroimmune mechanism in Alzheimer disease pathogenesis[J].Alzheimer Dis Assoc Disord,1994,8(3):149-158.
  • 7Rogers J,Webster S,Lue L F,et al.Inflammation and Alzheimers disease pathogenesis[J].Neurobio Aging,1996,17(5):681-686.
  • 8颜永刚,王玉,李博,等.太白洋参抗老年性痴呆有效部位药理筛选[C]//第四届中国中药商品学术大会暨中药鉴定学科教学改革与教材建设研讨会论文集.北京:北京中医药大学,2015:118-121.
  • 9雷国莲,杨文娟,颜永刚,黄广平.太白洋参颗粒治疗老年性痴呆的临床观察[J].国外医药(植物药分册),2008,23(5):208-210. 被引量:2
  • 10李国栋,袁保梅,鄢文海,邢莹.人参皂苷Rb1对内源性Aβ所致小鼠神经细胞Tau蛋白过磷酸化的干预作用[J].山东医药,2009,49(3):26-28. 被引量:3

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部